1

a:

.
.
.
.
/, .. ( ,
-). ( 15 )
0.15 (0.2-0.4) mg .
.
, .
.
.
0, 30%
. 0.1 mg .
, (
)!

, :

. . (
= 4.5-5.5..5.2-5.5; . = 1.1313-1.3) 5570%. , 7580% + 18
(melittin,apamin,MCD-peptide..). , +,Na+,Mg++,PO4=,
alanine, valine, arginine, tryptophan, methionin, histidine. ,
( 40 ).
. ()

, , , (
)

, ( , CaCl2 -250,3-4 )

(, ).

2
.
.

:
. ( , Muller,1998).
(, ,1983...).
200-500
.
, 20-50
. : .

(, , ,
, ).
.

"No Beneficial Effect of Bee Venom in Study Using Animal Model for MS". Multiple Sclerosis Society of Canada. 1998-06-02. Retrieved 2007-03-07. (
encephalitis :
. Allegheny University of the Health Sciences in Philadelphia.

"Apitherapy". American Cancer Society. November 2008. Retrieved 21 September 2013:

"there have been no clinical studies in humans showing that bee venom or other honeybee
products are effective in preventing or treating cancer."[3]

Jump up to:a b Castro, HJ; Mendez-Inocencio, JI; Omidvar, B; Omidvar, J; Santilli, J; Nielsen
Jr, HS; Pavot, AP; Richert, JR et al. (2005). "A phase I study of the safety of honeybee venom
extract as a possible treatment for patients with progressive forms of multiple
sclerosis". Allergy and asthma proceedings : the official journal of regional and state allergy
societies 26 (6): 4706. PMID 16541972.

A Phase I study at Georgetown University Medical Center funded by the Multiple Sclerosis
Association of America (MSAA) was geared towards safety in administering bee venom
treatments to humans with multiple sclerosis.[4] According to the authors, the study indicated
"there was little evidence to support the use of honeybee venom in the treatment of MS".[4]

Wesselius, T; Heersema, DJ; Mostert, JP; Heerings, M; Admiraal-Behloul, F; Talebian, A; Van Buchem,
MA; De Keyser, J (2005-12-13). "A randomized crossover study of bee sting therapy for multiple
sclerosis". Neurology 65 (11): 17641768. doi:10.1212/01.wnl.0000184442.02551.4b. PMID 16221950.
Retrieved 2011-04-10.A study at University Medical Center Groningen involved supervised bee sting
therapy (using live bees) administered to 26 patients over a period of 24 weeks, compared to a 24-week
period with no treatment. They concluded: in this trial, treatment with bee venom in patients with

3
relapsing multiple sclerosis did not reduce disease activity, disability, or fatigue and did not improve
quality of life.[5]

. ""
(o: , ).
/ .
3 200
.

,, , , ,
( , ,
, , , ...).
.

: -
/

, ,

()

(
):

(: ,
...)

; herpes zoster

(

)

melittin (52%

(, ,

,);,

4
, ,

2,
.
100 ;
Apamin (2-5%

HIV,
, -

,, -

;,

)
Peptide MDC (mast cells

degranulating)401
Adolapin (

)
(2%

,-

)
Secarpin
Procamine A,B
Hyaluronidase (1-3%

,
()-

Phospholipase A2 (,10-

,/ ;

12% ,)

:
, ,
;

Lysophospholipase
Histamine (0.5-2%
,
)
Dopamine/nor-adrenaline (1-2%

,
)
Tertiapin (,21

( -

, 2 +-

). - Na+-

5
:Kir,BK.

. -

,LD50 = 18-22

(KAch) AcChol

/kg bw ).

, -
(
Parasymp )

( 500 )

(), ( , ),
, , , (
, , , , = mixt
connec-tive tissue disease), discus hernia (
), ; lupus erythematodes
sistemicus...

, ,,, , , , ,
, .

/ ( )

,,

, ,

()

, , ,

, ,

(
)

, ()

, ( ), , ,

, ( )

( , )

()

" , ".
. ,
.
. ,
.
30 .
, , ,
5000 , (
).
(Veda), .

: ( )
.
.
. : 40
20 .
, ..)

( , , ..
""- ) .
.

( ).
( rhinosinusitis allergica). /:
!

20 ( 1 2
mg = 50 ). 1 24
000 29.000-99.000 .
10.000 15.000

(
)

(
) .

, ,,

Ateliers pratiques sur l'Apithrapie, l'Apiponcture, l'Api-Cosmetique, l'Api-Phytothrapie,

l'Api-Aromathrapie

/
(, , ) , , ,
, , ...

Chung Jin-Biotech (Korea)

(
)

(
1935 .:"The Bible od bee venom therapy,Dr
Bodog Beck)

Phillip Terc
(1888 "Report about a Peculiar Connection Between the Bee stings and Rheumatism);DrChalrles Mrac
(1905-1999)

Cochrans
evidence base medicine

( ),

( ) ,

( ). ,
, , , -, ,
- - .



.

:
1.
2.
(, , ...)
3.

4. /
( .melittin, adolapin, phospholipase A2, tertiapin..)
5. ,

8
6. , , ,
,

: . - .